Pharma Ignite retweeted
On Jan. 18, join our expert-led exclusive discussion on #AI adoption, external data trends and cycle time challenges. 💡 Gain insight into industry implications for the next 12 months in this live #PharmaIgnite/@CitelineClinSol webinar - register here: bit.ly/3RYmktX
Pharma Ignite retweeted
Replying to @PharmaIgnite
@Citeline I am glad to be attending the #CitelineAwards hosted by @JimmyTingle
The 2020 awards are virtual of course because of the #COVID19 #coronavirus #pandemic
Pharma Ignite retweeted
In this video extract I examine drugs in the pipeline by phase of development for 2017/18. The full Informa Tokyo presentation on Pharma R&D can be accessed here - https://xitter.gq/t.co/iQYJ8OMKrP #Pharma #DrugPipeline @Citeline @Pharma_Intell
Pharma Ignite retweeted
An amusing accompaniment for the #Pharma R&D annual review.
Listen to our special @Spotify playlist while you read @Citeline's Pharma R&D Annual REview. We hope you enjoy this tongue-in-cheek collection of songs, specially curated as the perfect accompaniment to this report. spoti.fi/2OxBhl8
Report: https://xitter.gq/t.co/Yoyr3uLR9U
Pharma Ignite retweeted
Listen to our special @Spotify playlist while you read @Citeline's Pharma R&D Annual REview. We hope you enjoy this tongue-in-cheek collection of songs, specially curated as the perfect accompaniment to this report. spoti.fi/2OxBhl8
Report: https://xitter.gq/t.co/Yoyr3uLR9U
Pharma Ignite retweeted
We surveyed 199 clinical trial professionals about the most hyped trends in clinical trials. Download the exclusive final report with an introduction from @citeline here spr.ly/6016DtcEI
Pharma Ignite retweeted
Delayed Reporting of Clinical Trial Starts - how will that influence your planned study? @Citeline can help: pharmaintelligence.informa.c…
Pharma Ignite retweeted
This is an important whitepaper detailing the constant challenges of implementing trials in preclinical #Alzheimer's
Alzheimer’s disease is one of the most daunting and intractable challenges facing health, social-care and economic systems worldwide. Read this new whitepaper from WCG and learn about the challenges of implementing trials in preclinical #Alzheimer’s. https://xitter.gq/t.co/o1V1bcs9U8
Pharma Ignite retweeted
We surveyed 199 clinical trial professionals about the most hyped trends in clinical trials. Download the exclusive final report with an introduction from @citeline here spr.ly/6014DtiCI
Pharma Ignite retweeted
Excellent infographic here on the #pharma market, particularly on companies merging as they aim to tap into therapeutic niches.
Pharma Ignite retweeted
Here's a short snippet from my colleague @CitelineIanL's presentation at Informa Tokyo, where he discusses Global R&D pipeline growth. You can also access the full video here - https://xitter.gq/t.co/u9c8YtvN0K @Citeline @Novartis @AstraZeneca @JNJCares @pfizer #pharma #drugs #novartis
Pharma Ignite retweeted
An insightful report by @Citeline @CitelineIanL detailing #pharma R&D in 2018 with comparison to 2017.
Breaking the pharma pipeline down its phases gives a bit more insight into the shape of the pharma industry in 2018. The graph below does just this, looking at the global status of each drug in the pipeline. https://xitter.gq/t.co/yWmwpNXSUX #PharmaIntelligence @Citeline
Pharma Ignite retweeted
Download our state of the industry report on strategic partnerships in clinical trials spr.ly/6019DtmPx #CRO #pharma #healthcare
Pharma Ignite retweeted
A significant proportion of #microbiome research is concentrated on gastrointestinal diseases. This paper looks at the disease areas receiving the most attention: https://xitter.gq/t.co/eAoI9Wknan #IBS @Citeline @CitelineHannahS
Pharma Ignite retweeted
We surveyed 199 clinical trial professionals about the most hyped trends in clinical trials. Download the exclusive final report with an introduction from @citeline here spr.ly/6012DsndY
Pharma Ignite retweeted
The work @PharmaScrip are doing on #Alzheimers disease is extremely important. Read their article on the challenges of designing and implementing trials in preclinical Alzheimer’s here:
Alzheimer’s disease is one of the most daunting and intractable challenges facing health, social-care and economic systems worldwide. Read this new whitepaper from WCG and learn about the challenges of implementing trials in preclinical #Alzheimer’s. https://xitter.gq/t.co/o1V1bcs9U8
Pharma Ignite retweeted
An interesting article here re BAN2401 and #Alzheimers disease:
#Biogen Inc. and Eisai Co. Ltd. reported that the highest dose of BAN2401 significantly cleared amyloid from the brain and improved cognition in patients with mild #Alzheimer's disease. Read More: https://xitter.gq/t.co/bdKMcA3p3H





















